Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03175640 · ClinicalTrials.gov registry record · NA
Prescribe to Save Lives
A NA study, sponsored by Baystate Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 294
- Enrollment target
NCT03175640: Completed NA study, sponsored by Baystate Medical Center.
NCT03175640 is a NA study that has completed, run by Baystate Medical Center. The registered enrollment target is 294 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03175640, a NA study, has completed, sponsored by Baystate Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 294 participants
- Enrollment target
Study Summary
The U.S. is in the midst of an epidemic of opioid overdose deaths. The common use of opioids among persons living with HIV, along with their common use of benzodiazepines, has resulted in high rates of opioid overdose among this population. This study will test the implementation of evidence-based training, mentoring, technical support, and academic detailing to encourage HIV physicians to adopt evidence-based interventions to reduce overdose risk and treat opioid addiction.
Primary Outcome
Number of clinicians that prescribe naloxone. This information will be collected from electronic medical record (EMR) data.
Interventions
- BEHAVIORAL Implementation intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 2017-07-12 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT03175640 record still lists
NCT03175640 is an interventional study that assigns participants to a tested intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which Implementation intervention is the first listed.
NCT03175640 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03175640 about?
NCT03175640 is a clinical study titled "Prescribe to Save Lives". The U.S. is in the midst of an epidemic of opioid overdose deaths. The common use of opioids among persons living with HIV, along with their common use of benzodiazepines, has resulted in high rates of opioid overdose among this population. This study will test the implementation of evidence-based t...
What is the current status of trial NCT03175640?
This trial is currently completed. It is a NA study. The enrollment target is 294 participants. The study started on 2017-07-12. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03175640?
The interventions under investigation include: Implementation intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03175640?
This trial is sponsored by Baystate Medical Center, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03175640's enrollment target sits among peer trials
294 373rd of 2000 higher than 1,626 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI